Background: Colorectal cancer (CRC) is the third leading cause of cancer-related mortality worldwide. Current systematic methods for diagnosing have inherent limitations so development of a minimally-invasive diagnosis, based on the identification of sensitive biomarkers in liquid biopsies could therefore facilitate screening among population at risk. Methods: In this study, we aim to develop a novel approach to identify highly sensitive and specific biomarkers by investigating the use of extracellular vesicles (EVs) isolated from the peritoneal lavage as a source of potential miRNA diagnostic biomarkers. We isolated EVs by ultracentrifugation from 25 ascitic fluids and 25 peritoneal lavages from non-cancer and CRC patients, respectively. A...
Since noninvasive biomarkers as an alternative to invasive colonoscopy to detect colorectal cancer (...
Peritoneal metastasis is the most frequent type of recurrence in patients with gastric cancer (GC) a...
Colorectal Cancer (CRC) is one of the deadliest cancers—ranking as the fourth most common cause of c...
Background: Colorectal cancer (CRC) is the third leading cause of cancer-related mortality worldwide...
Disseminated disease is present in ≈50% of colorectal cancer patients upon diagnosis, being responsi...
Disseminated disease is present in ≈50% of colorectal cancer patients upon diagnosis, being responsi...
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsible for mo...
Lung cancer is the leading cause of cancer-related deaths among men and women in the world, accounti...
Abstract: Endometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsi...
Extracellular vesicle (EV) microRNAs are of major interest as potential diagnostic biomarkers in all...
Abstract Background Extracellular vesicles (EVs) are considered as a new class of resources for pote...
Ovarian cancer is mostly diagnosed at advantaged stages due to the lack of early diagnostic biomarke...
Extracellular vesicles (EVs) are small vesicles released from cells. EVs represent an important mode...
New Zealand has one of the highest rates of colorectal cancer (CRC) in the world. Current strategies...
Colorectal cancer (CRC) is the third most common type of cancer worldwide amongst males and females....
Since noninvasive biomarkers as an alternative to invasive colonoscopy to detect colorectal cancer (...
Peritoneal metastasis is the most frequent type of recurrence in patients with gastric cancer (GC) a...
Colorectal Cancer (CRC) is one of the deadliest cancers—ranking as the fourth most common cause of c...
Background: Colorectal cancer (CRC) is the third leading cause of cancer-related mortality worldwide...
Disseminated disease is present in ≈50% of colorectal cancer patients upon diagnosis, being responsi...
Disseminated disease is present in ≈50% of colorectal cancer patients upon diagnosis, being responsi...
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsible for mo...
Lung cancer is the leading cause of cancer-related deaths among men and women in the world, accounti...
Abstract: Endometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsi...
Extracellular vesicle (EV) microRNAs are of major interest as potential diagnostic biomarkers in all...
Abstract Background Extracellular vesicles (EVs) are considered as a new class of resources for pote...
Ovarian cancer is mostly diagnosed at advantaged stages due to the lack of early diagnostic biomarke...
Extracellular vesicles (EVs) are small vesicles released from cells. EVs represent an important mode...
New Zealand has one of the highest rates of colorectal cancer (CRC) in the world. Current strategies...
Colorectal cancer (CRC) is the third most common type of cancer worldwide amongst males and females....
Since noninvasive biomarkers as an alternative to invasive colonoscopy to detect colorectal cancer (...
Peritoneal metastasis is the most frequent type of recurrence in patients with gastric cancer (GC) a...
Colorectal Cancer (CRC) is one of the deadliest cancers—ranking as the fourth most common cause of c...